Ask Dr Rosemary: 'Why hasn't testosterone gel boosted my sex drive?'
A reader wonders why hormone therapy hasn't boosted her libido - but seems to be giving her acne (Source: Daily Express - Health)
Source: Daily Express - Health - April 3, 2024 Category: Consumer Health News Source Type: news
Fracture Risk Bumped With Testosterone Therapy in Hypogonadal Men
(MedPage Today) -- Testosterone treatment didn't offer protection against fractures in men with hypogonadism, a TRAVERSE subtrial indicated.
Compared with placebo, men who were on a testosterone gel actually had a significantly higher risk for... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - January 17, 2024 Category: Endocrinology Source Type: news
Testosterone Treatments Aren ’ t Linked to Heart Risks When Patients Are Carefully Monitored, Study Finds
Advertisements for treatments for “low T,” or low testosterone levels in middle-aged and older men, have led to spikes in demand. But the safety and legitimacy of those testosterone therapies hasn’t been clear.
In a new study published in the New England Journal of Medicine and presented at the Endocrine Society’s annual meeting, researchers provide the most conclusive evidence yet that testosterone treatments appear to be safe for the heart and are not associated with an increased risk of certain heart-related events.
In the study, led by researchers at the Cleveland Clinic, more than 5,200 men age...
Source: TIME: Health - June 16, 2023 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized healthscienceclimate heart health Source Type: news
Big Trial Reassures on Heart Safety of Testosterone in Men Big Trial Reassures on Heart Safety of Testosterone in Men
' Real data on something that we ' ve been prescribing for decades, ' is how one expert describes the results of the FDA-mandated TRAVERSE trial of testosterone gel versus placebo in men with hypogonadism.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 16, 2023 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news
Sex boost on the NHS! 10-fold spike in women getting testosterone gel
The number of women prescribed testosterone gel on the NHS has increased ten-fold. It is recommended as a way to boost sex drive. But some experts say it is being overused. (Source: the Mail online | Health)
Source: the Mail online | Health - February 17, 2023 Category: Consumer Health News Source Type: news
Testim 1% (testosterone gel)
Title: Testim 1% (testosterone gel)Category: MedicationsCreated: 3/15/2021 12:00:00 AMLast Editorial Review: 3/15/2021 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - March 15, 2021 Category: Drugs & Pharmacology Source Type: news
Alembic Pharma's JV Aleor Dermaceuticals gets American regulator nod for Testosterone Gel
Aleor Dermaceuticals has received final approval from the US Food and Drug Administration (USFDA) for its ANDA for its abbreviated new drug application (ANDA) for Testosterone Gel, 1.62%, Alembic Pharmaceuticals said in a regulatory filing. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 4, 2021 Category: Pharmaceuticals Source Type: news
Alembic Pharma's JV Aleor Dermaceuticals gets tentative nod from USFDA for testosterone gel
Aleor Dermaceuticals has received tentative approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Testosterone Gel, 1.62 per cent (20.25 mg/1.25 gm actuation), Alembic Pharmaceuticals said in a regulatory filing. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 25, 2020 Category: Pharmaceuticals Source Type: news
testosterone gel (Androgel)
Title: testosterone gel (Androgel)Category: MedicationsCreated: 3/2/2005 12:00:00 AMLast Editorial Review: 7/5/2019 12:00:00 AM (Source: MedicineNet Mens Health General)
Source: MedicineNet Mens Health General - July 5, 2019 Category: Primary Care Source Type: news
Dr Reddy's launches generic testosterone gel in US market
The company's testosterone gel 1.62 per cent, which is a therapeutic equivalent generic version of AndroGel 1.62 per cent of AbbVie Inc, was approved USFDA. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 5, 2019 Category: Pharmaceuticals Source Type: news
Testosterone Gel 1% (New - Discontinuation)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - April 19, 2019 Category: Drugs & Pharmacology Source Type: news
Testosterone gel is safe for women with low sex drive
A new study says there's no evidence that testosterone significantly increases the risk of breast cancer in women — and it does improve their sex drive. (Source: the Mail online | Health)
Source: the Mail online | Health - November 12, 2018 Category: Consumer Health News Source Type: news
AbbVie Wins Reversal of $140 Mln Verdict in Case Over AndroGel Risks AbbVie Wins Reversal of $140 Mln Verdict in Case Over AndroGel Risks
A U.S. judge on Thursday overturned a $140.1 million verdict against AbbVie Inc in a lawsuit by a man who claimed the company misrepresented the risks of its testosterone replacement drug AndroGel, causing him to suffer a heart attack.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 9, 2018 Category: Consumer Health News Tags: Medscape Today News Source Type: news
AbbVie wins second AndroGel liability reversal
A U.S. judge overturned a $140.1 million verdict against AbbVie in a lawsuit by a man who claimed the drugmaker misrepresented the risks of its testosterone replacement drug AndroGel. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - July 9, 2018 Category: Pharmaceuticals Source Type: news
AbbVie wins reversal of $140 million verdict in case over AndroGel risks
A U.S. judge on Thursday overturned a $140.1 million verdict against AbbVie Inc in a lawsuit by a man who claimed the company misrepresented the risks of its testosterone replacement drug AndroGel, causing him to suffer a heart attack. (Source: Reuters: Health)
Source: Reuters: Health - July 6, 2018 Category: Consumer Health News Tags: healthNews Source Type: news
